LWLIVING WITH T1D
Living With T1D/August 14, 2026/3 min read

How Young-Onset Type 2 and Type 1 Diabetes Affect Quality of Life

A new study from Taiwan compares how adults with young-onset type 2 diabetes and type 1 diabetes experience their day-to-day lives. The findings reveal important differences in how each condition affects wellbeing, especially early on.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

living with t1dmental healthtechnologysupport

Key takeaways

  • Adults with young-onset type 2 diabetes reported slightly lower overall quality of life than those with type 1 diabetes, with the biggest gap in the first five years after diagnosis.
  • Despite having more serious health complications, young-onset type 2 diabetes patients reported lower diabetes-related distress than type 1 patients.
  • The differences in quality of life were modest and remained true even after accounting for age, lifestyle, other health conditions, and how well people's diabetes was controlled.
  • Understanding these differences can help healthcare providers better support patients with either condition during the critical early years.

Why This Study Matters

Type 2 diabetes is traditionally thought of as a condition affecting older adults. But young-onset type 2 diabetes—diagnosed in younger people—is becoming more common and often comes with more serious health complications earlier on. Type 1 diabetes, an autoimmune condition, follows a different path. While both conditions affect blood sugar, they develop differently and impact people in different ways.

Until now, there has been limited research comparing how living with young-onset type 2 diabetes versus type 1 diabetes affects people's everyday wellbeing and quality of life. This study set out to fill that gap by looking at real-world patient experiences in Taiwan.

What Researchers Found

The study included 1,442 adults: 603 with young-onset type 2 diabetes and 839 with type 1 diabetes. Researchers measured quality of life using two validated tools—the EQ-5D, which assesses general health and wellbeing, and the Diabetes-Related Distress Questionnaire, which focuses on stress and worry specific to managing diabetes.

Adults with young-onset type 2 diabetes reported lower scores on the general quality of life measure compared to those with type 1 diabetes (71.5 vs. 75.6 on a 100-point scale). This difference held true even after researchers accounted for factors like age, lifestyle habits, other health conditions, and how well people's blood sugar was controlled.

Interestingly, the gap was most noticeable during the first five years after diagnosis. After that, the differences narrowed. In contrast, adults with type 1 diabetes reported higher levels of diabetes-related distress and worry than those with young-onset type 2 diabetes.

What This Might Mean

The findings paint a complex picture. While young-onset type 2 diabetes patients experienced slightly lower overall quality of life—particularly early after diagnosis—they reported less diabetes-related emotional distress than type 1 patients. This suggests that the two conditions affect people differently, not just physically but emotionally and psychologically.

The heightened diabetes-related distress among type 1 patients may reflect the constant vigilance required to manage an autoimmune condition—frequent blood sugar checks, insulin dosing decisions, and unpredictable blood sugar swings. Young-onset type 2 patients may experience a different kind of burden related to the physical complications of their condition, while managing somewhat different daily stressors.

Limitations and Next Steps

This was a snapshot study conducted in Taiwan, so results may not apply equally to all populations or regions. The researchers also noted that while differences were statistically significant, they were modest in size, which is important to keep in mind when thinking about real-world impact.

Future research could explore what factors during those critical first five years drive differences in quality of life, and how healthcare systems can better tailor support for young adults with either condition. Understanding these nuances helps doctors and care teams provide more personalized, compassionate care.

Evidence label

Source: BMC endocrine disorders. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.